Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.

Zheng, Peijie; Zhou, Chuntao; Lu, Liuyi; Liu, Bin; Ding, Yuemin

Zheng, Peijie; Zhou, Chuntao; Lu, Liuyi; Liu, Bin; Ding, Yuemin.

Afiliación

Zheng P; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, 310015, China.
Zhou C; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, 310015, China.
Lu L; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, 310015, China.
Liu B; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, 310015, China.
Ding Y; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, 310015, China. dingyuemin@zucc.edu.cn.

J Exp Clin Cancer Res ; 41(1): 271, 2022 Sep 12.

Article en En | MEDLINE | ID: mdl-36089608

Asunto(s)

Cobre; Neoplasias; Cobre/metabolismo; Cobre/farmacología; Humanos; Hidrazinas; Ionóforos; Neoplasias/tratamiento farmacológico; Platino (Metal); Inhibidores de Proteasoma

Palabras clave

Anticancer drugs; Cancer; Cancer stem cells; Clinical trials; Cuproptosis; Drug safety; Elesclomol; Mitochondrial metabolism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cobre / Neoplasias Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google